MedWatch

Former Novo managers deny accusations in investor lawsuit

Former top managers in Novo Nordisk, Lars Rebien Sørensen, Jesper Brandgaard and Jakob Riis, deny the accusations from investors claiming that they were misled by the company regarding the price pressure on the US diabetes market. Nevertheless, the three ex-managers are now to stand trial in New Jersey, US.

Foto: Nils Meilvang/Scanpix

Five US pension funds have sued former CEO in Novo Nordisk Lars Rebien Sørensen, former Marketing Director Jakob Riis and resigning Executive Vice President of the Biopharm business Jesper Brandgaard for misleading Novo Nordisk's investors.

But in a 73-page document, the trio systematically deny the flood of accusations from investors who were allegedly hoodwinked by the Novo managers regarding the true status of the US diabetes market around 2015.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier